Showing results (131-140 of 164) with videos related to
Sort By:
Pageof 17
Oncology|September 5, 2022
SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved EquationMargarita Martín, Carmen Vallejo, Fernando López-Campos, et al.Clinical and Translational Radiation Oncology|March 11, 2026
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapyAndrea R Filippi, Jair Bar, Daniel C Christoph, et al.Cancer Epidemiology|August 17, 2015
Trends in survival of multiple myeloma: a thirty-year population-based study in a single institutionRafael Ríos-Tamayo, María José Sánchez, José Manuel Puerta, et al.Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.Journal for Immunotherapy of Cancer|May 8, 2021
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panelsJavier Ramos-Paradas, Susana Hernández-Prieto, David Lora, et al.The Oncologist|November 19, 2024
Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN studyAlfonso Cortés-Salgado, Juan José Serrano, David Cordero Pereda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R StudyNicolas Girard, Jair Bar, Pilar Garrido, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2022
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)Sai-Hong Ignatius Ou, Makoto Nishio, Myung-Ju Ahn, et al.European Eating Disorders Review : the Journal of the Eating Disorders Association|October 25, 2018
Food addiction and preoperative weight loss achievement in patients seeking bariatric surgeryFernando Guerrero Pérez, Jéssica Sánchez-González, Isabel Sánchez, et al.Investigational New Drugs|May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesotheliomaEmilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.Pageof 17